Kevin C. Johnson - 22 Dec 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Kevin C. Johnson
Issuer symbol
NEO
Transactions as of
22 Dec 2021
Net transactions value
+$24,238
Form type
4
Filing time
23 Dec 2021, 16:25:10 UTC
Previous filing
04 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $24,238 +3,334 +9.8% $7.27 37,398 22 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Options (Right to Buy) Options Exercise $0 -3,334 -100% $0.000000* 0 22 Dec 2021 Common Stock 3,334 $7.27 Direct F1
holding NEO Stock Options (Right to Buy) 4,269 22 Dec 2021 Common Stock 4,269 $22.52 Direct
holding NEO Stock Options (Right to Buy) 3,448 22 Dec 2021 Common Stock 3,448 $28.54 Direct
holding NEO Stock Options (Right to Buy) 3,714 22 Dec 2021 Common Stock 3,714 $40.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.